IP Verse

Pharmaceutical Compositions Comprising An S1p Modulator - EP3103448

PATENT ANALYSIS

Patent Details

Grant Date
Jul 3, 2019
Company
NOVARTIS AG
Oppositions

BLUEPHARMA INDUSTRIA FARMACEUTICA, S.A.

HELM AG

KRAUS & LEDERER PARTGMBB

KRKA, D.D., NOVO MESTO

LABORATORIOS LICONSA, S.A.

STADA ARZNEIMITTEL AG

ZENTIVA, K.S.

More patents of Novartis Ag

EP3124018

EP3023095

EP3626270

Want to monitor this patent?

Feel free to send us a message here and we will get back to you